サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1267401

プロテオミクスバイオマーカー解析市場：用途別、技術別、製品別、場所別予測 - カスタマイズ予測・分析を含むエグゼクティブコンサルタントガイド付き - 2023年～2027年

Proteomic Biomarker Analytics Markets. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027
出版日: | 発行: Howe Sound Research | ページ情報: 英文 269 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
プロテオミクスバイオマーカー解析市場：用途別、技術別、製品別、場所別予測 - カスタマイズ予測・分析を含むエグゼクティブコンサルタントガイド付き - 2023年～2027年
出版日: 2023年05月01日
発行: Howe Sound Research
ページ情報: 英文 269 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のプロテオミクスバイオマーカー解析市場について調査し、市場の概要とともに、用途別、技術別、製品別、場所別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 プロテオミクスバイオマーカー解析 - 技術ガイド

第4章 業界概要

  • 市場参入組織
  • 学術研究機関
  • 診断試験開発者
  • 計装サプライヤー
  • 薬品・試薬メーカー
  • 病理サプライヤー
  • 独立系臨床検査室
  • 公共の国立/地域研究所
  • 病院検査室
  • 臨床検査室
  • 監査機関
  • 認証機関

第5章 市場動向

  • 成長促進要因
  • 成長抑制要因

第6章 プロテオミクスバイオマーカー解析の最近の展開

第7章 プロテオミクスバイオマーカー解析 - 主要企業のプロファイル

  • Abbott Laboratories
  • Agilent/Dako
  • Amprion
  • BasePair Biotechnologies
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Bruker
  • C2N Diagnostics
  • Cepheid（Danaher）
  • Diadem Diagnostics
  • Eve Technologies
  • Fluidic Analytics
  • Fujirebio
  • Hybrigenics Services
  • Luminex Corp（DiaSorin）
  • NanoDx
  • Nautilus Biotechnology
  • Nicoya
  • Olink
  • Qiagen
  • Quanterix
  • Roche Molecular Diagnostics
  • Second Genome
  • Siemens Healthineers
  • Somalogic
  • Thermo Fisher Scientific Inc.

第8章 世界のプロテオミクスバイオマーカー解析市場

  • プロテオミクスバイオマーカー解析 - 国別の世界市場の概要
  • 用途別世界市場 - 概要
  • 技術別世界市場 - 概要
  • 製品別世界市場 - 概要
  • 場所別世界市場 - 概要

第9章 世界のプロテオミクスバイオマーカー解析市場 - 用途別

  • 創薬
  • 解析・研究
  • 臨床診断
  • その他

第10章 世界のプロテオミクスバイオマーカー解析市場 - 技術別

  • 質量分析
  • ELISA/ビーズ
  • ハイブリッドマルチプレックス
  • その他

第11章 世界のプロテオミクスバイオマーカー解析市場 - 製品別

  • 機器
  • キットと試薬
  • サービス

第12章 世界のプロテオミクスバイオマーカー解析市場 - 場所別

  • 学術機関
  • 製薬会社/バイオテクノロジー企業
  • 臨床
  • その他

第13章 付録

図表

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Three Factors Limiting Growth
  • Table 4: Market Size by Country
  • Table 5: Global Market by Application
  • Table 6: Global Market by Technology
  • Table 7: Global Market by Product
  • Table 8: Global Market by Place
  • Table 9: PROTEIN ANALYTICS Drug Discovery by Country
  • Table 10: PROTEIN ANALYTICS Research Application by Country
  • Table 11: PROTEIN ANALYTICS Clinical Dx by Country
  • Table 12: PROTEIN ANALYTICS Other Applications by Country
  • Table 13: PROTEIN ANALYTICS Mass Spectrometry by Country
  • Table 14: PROTEIN ANALYTICS Hybrid Multiplex by Country
  • Table 15: PROTEIN ANALYTICS Other Technology by Country
  • Table 16: PROTEIN ANALYTICS Instruments by Country
  • Table 17: PROTEIN ANALYTICS Kits & Reagents by Country
  • Table 18: PROTEIN ANALYTICS Services by Country
  • Table 19: PROTEIN ANALYTICS Academic by Country
  • Table 20: PROTEIN ANALYTICS Pharma/Biotech by Country
  • Table 21: PROTEIN ANALYTICS Clinical by Country
  • Table 22: PROTEIN ANALYTICS Other Place by Country
  • Table 23: The Most Common Assays
  • Table 24: Largest Revenue Assays

Table of Figures

  • Figure 1: The Road to Diagnostics
  • Figure 2: Base year Global Market Share Chart
  • Figure 3: PROTEIN ANALYTICS Market by Application - Segments Growth
  • Figure 4: PROTEIN ANALYTICS Market by Application - Base vs. final
  • Figure 5: PROTEIN ANALYTICS Market Base year
  • Figure 6: PROTEIN ANALYTICS Market Final Year
  • Figure 7: PROTEIN ANALYTICS Application Share by Year
  • Figure 8: PROTEIN ANALYTICS Market by Technology - Segments Growth
  • Figure 9: PROTEIN ANALYTICS Market by Technology - Base vs. final
  • Figure 10: PROTEIN ANALYTICS Market by Technology Base year
  • Figure 11: PROTEIN ANALYTICS Market by Technology Final Year
  • Figure 12: PROTEIN ANALYTICS Technology Share by Year
  • Figure 13: PROTEIN ANALYTICS Market by Product - Segments Growth
  • Figure 14: PROTEIN ANALYTICS Market by Product - Base vs. final
  • Figure 15: PROTEIN ANALYTICS Market by Product Base year
  • Figure 16: PROTEIN ANALYTICS Market by Product Final Year
  • Figure 17: Product Share by Year
  • Figure 18: PROTEIN ANALYTICS Market by Place - Segments Growth
  • Figure 19: PROTEIN ANALYTICS Market by Place - Base vs. final
  • Figure 20: PROTEIN ANALYTICS Market by Place Base year
  • Figure 21: PROTEIN ANALYTICS Market by Place Final Year
  • Figure 22: Place Share by Year
  • Figure 23: PROTEIN ANALYTICS Drug Discovery Growth
  • Figure 24: PROTEIN ANALYTICS Research Application Growth
  • Figure 25: PROTEIN ANALYTICS Clinical Dx Growth
  • Figure 26: PROTEIN ANALYTICS Other Applications Growth
  • Figure 27: PROTEIN ANALYTICS Mass Spectrometry Growth
  • Figure 28: PROTEIN ANALYTICS ELISA/Beads Growth
  • Figure 29: PROTEIN ANALYTICS Hybrid Multiplex Growth
  • Figure 30: PROTEIN ANALYTICS Other Technology Growth
  • Figure 31: PROTEIN ANALYTICS Instruments Growth
  • Figure 32: PROTEIN ANALYTICS Kits & Reagents Growth
  • Figure 33: PROTEIN ANALYTICS Services Growth
  • Figure 34: PROTEIN ANALYTICS Academic Growth
  • Figure 35: PROTEIN ANALYTICS Pharma/Biotech Growth
  • Figure 36: PROTEIN ANALYTICS Clinical Growth
  • Figure 37: PROTEIN ANALYTICS Other Place Growth
目次

OVERVIEW:

Proteomics is going mainstream. Where genomics couldn't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What is Proteomic Biomarker Analytics?
  • 2.2. Proteomics and Drug Development
  • 2.3. Market Definition
    • 2.3.1. Market Size
    • 2.3.2. Currency
    • 2.3.3. Years
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors

3. Proteomic Biomarker Analytics - Guide to Technologies

  • 3.1. Methods
    • 3.1.1. Separation techniques and electrophoresis
    • 3.1.2. Mass spectrometry
    • 3.1.3. Chromatography
    • 3.1.4. Blotting
    • 3.1.5. Protein complementation assays and interaction screens
    • 3.1.6. Protein structure prediction
    • 3.1.7. Protein databases

4. Industry Overview

  • 4.1. Players in a Dynamic Market
  • 4.2. Academic Research Lab
  • 4.3. Diagnostic Test Developer
  • 4.4. Instrumentation Supplier
  • 4.5. Chemical/Reagent Supplier
  • 4.6. Pathology Supplier
  • 4.7. Independent Clinical Laboratory
  • 4.8. Public National/regional Laboratory
  • 4.9. Hospital Laboratory
  • 4.10. Physicians Office Lab (POLS)
  • 4.11. Audit Body
  • 4.12. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Drug Development
    • 5.1.2. Companion Dx
    • 5.1.3. Fertile Research
    • 5.1.4. Technology Convergence
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve
    • 5.2.2. Capacity Constraints
    • 5.2.3. Market Lag

6. Proteomic Analytics Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Amprion's Parkinson's Disease Dx Shows Strong Performance
  • 6.3. Single-Cell Proteomics Bypasses Bottlenecks
  • 6.4. SomaLogic Seeks 'Strategic Alternatives' for Dx Business
  • 6.5. Alzheimer's Dx Study to Add Genomic, Proteomic Profiling
  • 6.6. NanoDx Prepares for POC Platform Commercialization
  • 6.7. DeepMind AI Predicts 3D Structure of Every Protein
  • 6.8. Quanterix Slashing Workforce by 25 Percent
  • 6.9. Study Shows Potential of NanoMosaic's Platform for Biomarker Development
  • 6.10. Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra
  • 6.11. PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications
  • 6.12. Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
  • 6.13. Proteomics Goes Public

7. Profiles of Key Proteomic Biomarker Analytic Companies

  • 7.1. Abbott Laboratories
  • 7.2. Agilent/Dako
  • 7.3. Amprion
  • 7.4. BasePair Biotechnologies
  • 7.5. Beckman Coulter Diagnostics
  • 7.6. Becton, Dickinson and Company
  • 7.7. Bio-Rad Laboratories, Inc.
  • 7.8. Bio-Techne
  • 7.9. Bruker
  • 7.10. C2N Diagnostics
  • 7.11. Cepheid (Danaher)
  • 7.12. Diadem Diagnostics
  • 7.13. Eve Technologies
  • 7.14. Fluidic Analytics
  • 7.15. Fujirebio
  • 7.16. Hybrigenics Services
  • 7.17. Luminex Corp (DiaSorin)
  • 7.18. NanoDx
  • 7.19. Nautilus Biotechnology
  • 7.20. Nicoya
  • 7.21. Olink
  • 7.22. Qiagen
  • 7.23. Quanterix
  • 7.24. Roche Molecular Diagnostics
  • 7.25. Second Genome
  • 7.26. Siemens Healthineers
  • 7.27. Somalogic
  • 7.28. Thermo Fisher Scientific Inc.

8. Global Proteomic Analytics Markets

  • 8.1. PROTEIN ANALYTICS - Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Market by Application - Overview
    • 8.2.1. Table - Global Market by Application
    • 8.2.2. Chart - Global Market by Application - Segments Growth
    • 8.2.3. Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4. Chart - Global Market by Application - Base Year
    • 8.2.5. Chart - Global Market by Application - Final Year
    • 8.2.6. Chart - Global Market by Application - Share by Year
  • 8.3. Global Market by Technology - Overview
    • 8.3.1. Table - Global Market by Technology
    • 8.3.2. Chart - Global Market by Technology - Segments Growth
    • 8.3.3. Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4. Chart - Global Market by Technology - Base Year
    • 8.3.5. Chart - Global Market by Technology - Final Year
    • 8.3.6. Chart - Global Market by Technology - Share by Year
  • 8.4. Global Market by Product - Overview
    • 8.4.1. Table - Global Market by Product
    • 8.4.2. Chart - Global Market by Product - Segments Growth
    • 8.4.3. Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4. Chart - Global Market by Product - Base Year
    • 8.4.5. Chart - Global Market by Product - Final Year
    • 8.4.6. Chart - Global Market by Product - Share by Year
  • 8.5. Global Market by Place - Overview
    • 8.5.1. Table - Global Market by Place
    • 8.5.2. Chart - Global Market by Place - Segments Growth
    • 8.5.3. Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4. Chart - Global Market by Place - Base Year
    • 8.5.5. Chart - Global Market by Place - Final Year
    • 8.5.6. Chart - Global Market by Place - Share by Year

9. Global PROTEIN ANALYTICS Markets - By Application

  • 9.1. PROTEIN ANALYTICS Drug Discovery
    • 9.1.1. Table PROTEIN ANALYTICS Drug Discovery - by Country
    • 9.1.2. Chart - PROTEIN ANALYTICS Drug Discovery Growth
  • 9.2. PROTEIN ANALYTICS Research Application
    • 9.2.1. Table PROTEIN ANALYTICS Research Application - by Country
    • 9.2.2. Chart - PROTEIN ANALYTICS Research Application Growth
  • 9.3. PROTEIN ANALYTICS Clinical Dx
    • 9.3.1. Table PROTEIN ANALYTICS Clinical Dx - by Country
    • 9.3.2. Chart - PROTEIN ANALYTICS Clinical Dx Growth
  • 9.4. PROTEIN ANALYTICS Other Applications
    • 9.4.1. Table PROTEIN ANALYTICS Other Applications - by Country
    • 9.4.2. Chart - PROTEIN ANALYTICS Other Applications Growth

10. Global PROTEIN ANALYTICS Markets - By Technology

  • 10.1. PROTEIN ANALYTICS Mass Spectrometry
    • 10.1.1. Table PROTEIN ANALYTICS Mass Spectrometry - by Country
    • 10.1.2. Chart - PROTEIN ANALYTICS Mass Spectrometry Growth
  • 10.2. PROTEIN ANALYTICS ELISA/Beads
    • 10.2.1. Table PROTEIN ANALYTICS ELISA/Beads - by Country
    • 10.2.2. Chart - PROTEIN ANALYTICS ELISA/Beads Growth
  • 10.3. PROTEIN ANALYTICS Hybrid Multiplex
    • 10.3.1. Table PROTEIN ANALYTICS Hybrid Multiplex - by Country
    • 10.3.2. Chart - PROTEIN ANALYTICS Hybrid Multiplex Growth
  • 10.4. PROTEIN ANALYTICS Other Technology
    • 10.4.1. Table PROTEIN ANALYTICS Other Technology - by Country
    • 10.4.2. Chart - PROTEIN ANALYTICS Other Technology Growth

11. Global PROTEIN ANALYTICS Markets - By Product

  • 11.1. PROTEIN ANALYTICS Instruments
    • 11.1.1. Table PROTEIN ANALYTICS Instruments - by Country
    • 11.1.2. Chart - PROTEIN ANALYTICS Instruments Growth
  • 11.2. PROTEIN ANALYTICS Kits & Reagents
    • 11.2.1. Table PROTEIN ANALYTICS Kits & Reagents - by Country
    • 11.2.2. Chart - PROTEIN ANALYTICS Kits & Reagents Growth
  • 11.3. PROTEIN ANALYTICS Services
    • 11.3.1. Table PROTEIN ANALYTICS Services - by Country
    • 11.3.2. Chart - PROTEIN ANALYTICS Services Growth

12. Global PROTEIN ANALYTICS Markets - By Place

  • 12.1. PROTEIN ANALYTICS Academic
    • 12.1.1. Table PROTEIN ANALYTICS Academic - by Country
    • 12.1.2. Chart - PROTEIN ANALYTICS Academic Growth
  • 12.2. PROTEIN ANALYTICS Pharma/Biotech
    • 12.2.1. Table PROTEIN ANALYTICS Pharma/Biotech - by Country
    • 12.2.2. Chart - PROTEIN ANALYTICS Pharma/Biotech Growth
  • 12.3. PROTEIN ANALYTICS Clinical
    • 12.3.1. Table PROTEIN ANALYTICS Clinical - by Country
    • 12.3.2. Chart - PROTEIN ANALYTICS Clinical Growth
  • 12.4. PROTEIN ANALYTICS Other Place
    • 12.4.1. Table PROTEIN ANALYTICS Other Place - by Country
    • 12.4.2. Chart - PROTEIN ANALYTICS Other Place Growth

13. Appendices

  • 13.1. Clinical Laboratory Fee Schedule
  • 13.2. The Most Used IVD Assays
  • 13.3. The Highest Grossing Assays